Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT02560753 · COMPLETED
Trial details
- NCT number
- NCT02560753
- Sponsor
- T3D Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-05-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.